UK markets close in 5 hours 48 minutes
  • FTSE 100

    6,654.47
    +3.59 (+0.05%)
     
  • FTSE 250

    21,200.89
    -95.34 (-0.45%)
     
  • AIM

    1,164.08
    -9.31 (-0.79%)
     
  • GBP/EUR

    1.1559
    -0.0037 (-0.32%)
     
  • GBP/USD

    1.3801
    -0.0093 (-0.67%)
     
  • BTC-GBP

    33,994.95
    -1,711.00 (-4.79%)
     
  • CMC Crypto 200

    938.63
    -48.58 (-4.92%)
     
  • S&P 500

    3,768.47
    -51.25 (-1.34%)
     
  • DOW

    30,924.14
    -345.95 (-1.11%)
     
  • CRUDE OIL

    65.10
    +1.27 (+1.99%)
     
  • GOLD FUTURES

    1,692.40
    -8.30 (-0.49%)
     
  • NIKKEI 225

    28,864.32
    -65.79 (-0.23%)
     
  • HANG SENG

    29,098.29
    -138.50 (-0.47%)
     
  • DAX

    13,942.34
    -114.00 (-0.81%)
     
  • CAC 40

    5,795.50
    -35.15 (-0.60%)
     

Smoking Cessation & Nicotine De-Addiction Product Market Research Report by Product, by Distribution - Global Forecast to 2025 - Cumulative Impact of COVID-19

ReportLinker
·6-min read

Smoking Cessation & Nicotine De-Addiction Product Market Research Report by Product (Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, and Nicotine Sublingual Tablets), by Distribution (Drug Store, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies) - Global Forecast to 2025 - Cumulative Impact of COVID-19

New York, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Smoking Cessation & Nicotine De-Addiction Product Market Research Report by Product, by Distribution - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06015785/?utm_source=GNW

Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Smoking Cessation & Nicotine De-Addiction Product Market is expected to grow from USD 21,738.21 Million in 2020 to USD 33,807.33 Million by the end of 2025.
2. The Global Smoking Cessation & Nicotine De-Addiction Product Market is expected to grow from EUR 19,060.48 Million in 2020 to EUR 29,642.90 Million by the end of 2025.
3. The Global Smoking Cessation & Nicotine De-Addiction Product Market is expected to grow from GBP 16,944.80 Million in 2020 to GBP 26,352.61 Million by the end of 2025.
4. The Global Smoking Cessation & Nicotine De-Addiction Product Market is expected to grow from JPY 2,320,018.46 Million in 2020 to JPY 3,608,098.83 Million by the end of 2025.
5. The Global Smoking Cessation & Nicotine De-Addiction Product Market is expected to grow from AUD 31,566.78 Million in 2020 to AUD 49,092.74 Million by the end of 2025.

Market Segmentation & Coverage:
This research report categorizes the Smoking Cessation & Nicotine De-Addiction Product to forecast the revenues and analyze the trends in each of the following sub-markets:

"The Nicotine Replacement Therapies is projected to witness the highest growth during the forecast period"

Based on Product, the Smoking Cessation & Nicotine De-Addiction Product Market studied across Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, and Nicotine Sublingual Tablets. The Drug Therapy further studied across Chantix (Varenicline) and Zyban (Bupropion). The Nicotine Replacement Therapies further studied across Nicotine Gums, Nicotine Lozenges, Nicotine Sprays, and Nicotine Transdermal Patches. The Drug Therapy commanded the largest size in the Smoking Cessation & Nicotine De-Addiction Product Market in 2020. On the other hand, the Nicotine Replacement Therapies is expected to grow at the fastest CAGR during the forecast period.

"The Online Pharmacies is projected to witness the highest growth during the forecast period"

Based on Distribution, the Smoking Cessation & Nicotine De-Addiction Product Market studied across Drug Store, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Hospital Pharmacies commanded the largest size in the Smoking Cessation & Nicotine De-Addiction Product Market in 2020. On the other hand, the Online Pharmacies is expected to grow at the fastest CAGR during the forecast period.

"The Americas is projected to witness the highest growth during the forecast period"

Based on Geography, the Smoking Cessation & Nicotine De-Addiction Product Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Smoking Cessation & Nicotine De-Addiction Product Market in 2020. On the other hand, the Americas is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Smoking Cessation & Nicotine De-Addiction Product Market including 22nd Century Group, Inc., Axsome Therapeutics, Inc., British American Tobacco PLC, Cipla Ltd., Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Imperial Tobacco Company of India Limited, Japan Tobacco Inc., Johnson & Johnson, JUUL Labs Inc., NJOY, Inc., Novartis International AG, Perrigo Company PLC, Pfizer, Inc., Philip Morris International Inc., Revolymer PLC by Itaconix, and Takeda Pharmaceutical Co., Ltd..

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™ FPNV Positioning Matrix:
The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Smoking Cessation & Nicotine De-Addiction Product Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™ Competitive Strategic Window:
The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Smoking Cessation & Nicotine De-Addiction Product Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Smoking Cessation & Nicotine De-Addiction Product Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Smoking Cessation & Nicotine De-Addiction Product Market?
4. What is the competitive strategic window for opportunities in the Global Smoking Cessation & Nicotine De-Addiction Product Market?
5. What are the technology trends and regulatory frameworks in the Global Smoking Cessation & Nicotine De-Addiction Product Market?
6. What are the modes and strategic moves considered suitable for entering the Global Smoking Cessation & Nicotine De-Addiction Product Market?
Read the full report: https://www.reportlinker.com/p06015785/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001